These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24888947)

  • 1. Microbiological profile and biofilm formation on removed intrauterine contraceptive devices from a sample of Egyptian women.
    Abdel-Hafeez M; El-Mehallaway N; Khalil I; Abdallah F; Elnaggar A
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1770-6. PubMed ID: 24888947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium.
    Ocak S; Cetin M; Hakverdi S; Dolapcioglu K; Gungoren A; Hakverdi AU
    Saudi Med J; 2007 May; 28(5):727-31. PubMed ID: 17457440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
    Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial and cytopathological study of intrauterine contraceptive device users.
    Agarwal K; Sharma U; Acharya V
    Indian J Med Sci; 2004 Sep; 58(9):394-9. PubMed ID: 15470281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
    Neale R; Knight I; Keane F
    Int J STD AIDS; 2009 Jun; 20(6):423-4. PubMed ID: 19451330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culture- and PCR-based detection of BV associated microbiological profile of the removed IUDs and correlation with the time period of IUD in place and the presence of the symptoms of genital tract infection.
    Ádám A; Pál Z; Terhes G; Szűcs M; Gabay ID; Urbán E
    Ann Clin Microbiol Antimicrob; 2018 Nov; 17(1):40. PubMed ID: 30466466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of Candida infection with intrauterine contraceptive device.
    Demirezen S; Dirlik OO; Beksaç MS
    Cent Eur J Public Health; 2005 Mar; 13(1):32-4. PubMed ID: 15859178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actinomyces species associated with intrauterine contraceptive devices and pelvic inflammatory disease.
    Tendolkar U; Pandit D; Khatri M; Deodhar L
    Indian J Pathol Microbiol; 1993 Jul; 36(3):238-44. PubMed ID: 8300169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidiasis in women fitted with an intrauterine contraceptive device.
    Parewijck W; Claeys G; Thiery M; van Kets H
    Br J Obstet Gynaecol; 1988 Apr; 95(4):408-10. PubMed ID: 3382616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiology of vaginitis associated with the intrauterine contraceptive device.
    Kivijärvi A; Järvinen H; Grönroos M
    Br J Obstet Gynaecol; 1984 Sep; 91(9):917-23. PubMed ID: 6332643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An analysis of complications and bacteriological and histological studies following extraction of an intrauterine contraceptive device (Beospir) which was inserted several years ago].
    Kracunović M; Oprić M
    Jugosl Ginekol Opstet; 1980; 19(3-4):191-4. PubMed ID: 7412377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichomonas vaginalis in vaginal smears of women using intrauterine contraceptive device.
    Demirezen S
    Cent Eur J Public Health; 2001 Nov; 9(4):176-8. PubMed ID: 11787243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trend in the use of intra-uterine contraceptive device (IUCD ,TCU 380A), in Enugu, Nigeria.
    Ezegwui HU; Nwogu-Ikojo EE; Ikeako LC; Nweze S
    Niger J Med; 2013; 22(3):193-7. PubMed ID: 24180146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytopathologic changes associated with intrauterine contraceptive devices. A review of cervico-vaginal smears in 350 women.
    Pillay B; Gregory AR; Subbiah M
    Med J Malaysia; 1994 Mar; 49(1):74-7. PubMed ID: 8057995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of bacteria in the vagina of normal young women.
    Watt B; Goldacre MJ; Loudon N; Annat DJ; Harris RI; Vessey MP
    Br J Obstet Gynaecol; 1981 Jun; 88(6):588-95. PubMed ID: 7248215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesical calculus: a complication of intravesical migration of intrauterine contraceptive device.
    Rafique M
    Int Urogynecol J Pelvic Floor Dysfunct; 2002 Nov; 13(6):380-2. PubMed ID: 12466910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of intrauterine contraceptive device at caesarean section.
    Bhutta SZ; Butt IJ; Bano K
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):527-30. PubMed ID: 21914407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of extrauterine mislocated intrauterine contraceptive devices and related risks.
    Şengül Ö; Dilbaz B; Kavak D; Dede S; Yerebasmaz N; Altinbaş Ş
    J Obstet Gynaecol; 2014 Jan; 34(1):70-3. PubMed ID: 24359055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysteroscopic removal of intrauterine contraceptive device embedded within submucous myoma.
    Wang JH; Wang LQ; Shang-Guan XJ; Huang LL
    Aust N Z J Obstet Gynaecol; 2010 Aug; 50(4):397-9. PubMed ID: 20716271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis.
    Auler ME; Morreira D; Rodrigues FF; Abr Ao MS; Margarido PF; Matsumoto FE; Silva EG; Silva BC; Schneider RP; Paula CR
    Med Mycol; 2010 Feb; 48(1):211-6. PubMed ID: 20055746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.